- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lenalidomide (Revlimid®)
Total 14716 results
-
St. Joseph's Hospital and Medical Center, PhoenixThe Cleveland Clinic; National Institute on Aging (NIA)RecruitingCognitive Dysfunction | Neurodegeneration | Cognitive Impairment, Mild | Amyloid Plaque | Inflammation, BrainUnited States
-
University of LeedsCelgene Corporation; Oncolytics Biotech; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
Beth Israel Deaconess Medical CenterAmerican Medical AssociationCompletedAcute Respiratory FailureUnited States
-
Attaya SuvannasankhaCelgeneCompletedLenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple MyelomaMultiple MyelomaUnited States
-
Medical College of WisconsinRecruiting
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
University of ChicagoRecruiting
-
Massachusetts General HospitalMultiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
University of ChicagoBristol-Myers Squibb; Amgen; Multiple Myeloma Research FoundationActive, not recruitingMultiple MyelomaUnited States
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell LymphomaUnited States
-
University of ArkansasWithdrawn
-
Gilead SciencesCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaUnited States
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Sun Yat-sen... and other collaboratorsRecruitingFollicular Lymphoma | DLBCL - Diffuse Large B Cell LymphomaChina
-
Institute of Hematology & Blood Diseases HospitalRecruitingMarginal Zone LymphomaChina
-
Memorial Sloan Kettering Cancer CenterColumbia University; Montefiore Medical Center; Weill Medical College of Cornell... and other collaboratorsCompleted
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Fondazione Italiana Linfomi ONLUSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Samsung Medical CenterRecruiting
-
University of ChicagoCelgene CorporationCompleted
-
University of BolognaTerminated
-
Institut Paoli-CalmettesCompletedNon-Hodgkin LymphomaFrance
-
Roswell Park Cancer InstituteCelgeneCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Robert Dreicer MDNational Cancer Institute (NCI)Completed
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Beth ChristianGenentech, Inc.; CelgeneActive, not recruitingRecurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Burkitt Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States
-
Ajai ChariNovartis PharmaceuticalsCompletedMultiple MyelomaUnited States
-
Hearn Jay ChoBristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Leap Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityOnyx Therapeutics, Inc.Active, not recruiting
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene CorporationTerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Beijing Mabworks Biotech Co., Ltd.RecruitingFollicular Lymphoma and Marginal Zone LymphomaChina
-
Hackensack Meridian HealthCelgene CorporationCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Oslo University HospitalHelse Stavanger HF; St. Olavs Hospital; Nordic Myeloma Study GroupActive, not recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene Corporation; Biologics...CompletedRelapsed/Refractory Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
Guangdong Provincial People's HospitalGuangzhou First People's Hospital; Foshan First People's Hospital; Huizhou Municipal... and other collaboratorsRecruitingDiffuse Large B Cell Lymphoma | Age Over 80 YearsChina
-
Institut Paoli-CalmettesCompletedAcute Myeloid Leukemia or Myelodysplasic SyndromeFrance
-
M.D. Anderson Cancer CenterCompletedSolid TumorsUnited States
-
Fondazione EMN Italy OnlusActive, not recruiting
-
Peter MacCallum Cancer Centre, AustraliaAbbVieNot yet recruitingRelapsed/Refractory Large B-cell LymphomaAustralia
-
Kim, Seok JinCelltrion; Samyang Biopharmaceuticals CorporationRecruitingPrimary CNS LymphomaKorea, Republic of
-
Fudan UniversityCompletedDouble Expressor LymphomaChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene CorporationCompletedRecurrent Follicular LymphomaUnited States